Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NOACs
Pharma
BMS, Pfizer's Eliquis tops warfarin in high-risk afib group
Eliquis has new data showing the next-gen anticoagulant is safer than warfarin for a tough-to-treat group of atrial fibrillation patients.
Carly Helfand
Mar 17, 2019 11:47am
J&J makes Xarelto case for clot prevention in cancer
Dec 4, 2018 10:30am
BMS, Pfizer's Eliquis to unseat warfarin in 'weeks': exec
Jul 30, 2018 10:31am
BMS surprise: Opdivo stands its ground in lung cancer
Jul 26, 2018 12:23pm
Eliquis' growth ceiling is nowhere in sight: BMS CEO
Jan 10, 2018 11:25am
J&J's Xarelto pads artery disease case with amputation data
Nov 15, 2017 10:30am
